Evaluation of a new condensed extra-corporeal circuit for cardiac surgery: A prospective randomized clinical pilot study

Perfusion

Volumn 20, Issue 2, 2005, Pages 91-99

  Fransen, Erik J ^a   Ganushchak, Yuri M ^a   Vijay, Ventakaramana ^b   de Jong, Dick S ^a   Buurman, Wim A ^a   Maessen, Jos G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; HEMOGLOBIN; HEPARIN; INTERLEUKIN 6; PROTAMINE; TROPONIN T;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART SURGERY; HEMOLYSIS; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE ACTIVATION; MALE; OXYGENATOR; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAFETY; TREATMENT OUTCOME;

ACUTE-PHASE PROTEINS; CARDIOPULMONARY BYPASS; COMPLEMENT C3B; COMPLEMENT C4B; CORONARY ARTERY BYPASS; EVALUATION STUDIES; HEMOLYSIS; HEPARIN; NEUTROPHIL ACTIVATION; PEPTIDE FRAGMENTS; PILOT PROJECTS; TROPONIN T;

EID: 18844434720     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659105pf795oa     Document Type: Article

References (28)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
2. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987; 13: 89-95.
3. Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 1998; 113: 1290-95.
4. Fosse E, Mollnes TE, Ingvaldsen B. Complement activation during major operations with or without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 93: 860-66.
5. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008-16.
6. Harlan JM. Neutrophil-mediated vascular injury. Acta Med Scand Suppl 1987; 715: 123-29.
7. Bouma M, Maessen J, Weerwind P et al. Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study. Chest 1997; 111: 577-83.
8. Weerwind PW, Maessen JG, van Tits LJH et al. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. J Thorac Cardiovasc Surg 1995; 110: 1633-41.
9. McCusker K, Vijay V, DeBois W, Helm R, Sisto D. MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. Perfusion 2001; 16: 447-52.
10. McCusker K, Vijay V, Helm R. Clinical outcomes of complete x-coating circuit in MAST condensed bypass setting. J Extra Corporeal Technology 2002; 34: 41-78.
11. Hack CE, Paardekooper J, Smeenk RJ, Abbink J, Eerenberg AJ, Nuijens JH. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. J Immunol 1988; 141: 1602-609.
12. Wolbink GJ, Bollen J, Baars JW et al. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods 1993; 163: 67-76.
13. Dentener MA, Francot GJM, Smit FT et al. Presence of bactericidal/permeability-increasing protein in disease: detection by ELISA. J Infect Dis 1995; 171: 739-43.
14. van Dielen FM, van't Veer C, Schols AM, Soeters PB, Buurman WA, Greve JW. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 2001; 25: 1759-66.
15. Dentener MA, Bazil V, Von Asmuth EJU, Ceska M, Buurman WA. Involvement of CD14 in lipopolysac-charide-induced tumor necrosis factor-a, IL-6 and IL-8 release by human monocytes and alveolar macro-phages. J Immunol 1993; 150: 2885-91.
16. Boyden A, Button E, Germerog D. Precipitin testing with special reference to the measurement of turbidity. J Immunol 1947; 57: 211.
17. Hellsing K. The effects of different polymers for enhancement of the antigen-antibody reaction as measured with nephelometry. Protides of the Biological Fluids 1973; 23: 579.
18. Saito N, Motoyama S, Sawamoto J. Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass. Artif Organs 2000; 24: 547-54.
19. Suhara H, Sawa Y, Nishimura M et al. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg 2001; 71: 1603-608.
20. Gu YJ, Mariani MA, Boonstra PW, Grandjean JG, van Oeveren W. Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: the role of tissue injury by surgical incision. Chest 1999; 116: 892-98.
21. Fosse E, Pillgram-Larsen J, Svennevig JL et al. Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury 1998; 29: 509-14.
22. Benedetti M, De Caterina R, Bionda A et al. Blood-artificial surface interactions during cardiopulmonary bypass. A comparative study of four oxygenators. Int J Artif Organs 1990; 13: 488-97.
23. Matata BM, Sosnowski AW, Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 2000; 69: 785-91.
24. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery [see comments]. Chest 1999; 116: 1233-39.
25. Gu YJ, van Oeveren W, Boonstra PW, De Haan J, Wildevuur CRH. Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass. Ann Thorac Surg 1992; 53: 839-43.
26. Hansbro SD, Sharpe DA, Catchpole R et al. Haemolysis during cardiopulmonary bypass: an in vivo comparison of standard roller pumps, nonocclusive roller pumps and centrifugal pumps. Perfusion 1999; 14: 3-10.
27. Pierangeli A, Masieri V, Bruzzi F et al. Haemolysis during cardiopulmonary bypass: how to reduce the free haemoglobin by managing the suctioned blood separately. Perfusion 2001; 16: 519-24.
28. Fransen EJ, Diris JHC, Maessen JG, Hermens WT, van Dieijen-Visser MP. Evaluation of "new" cardiac markers for ruling out myocardial infarction after coronary artery bypass grafting. Chest 2002; 122: 1316-21.